Evidence map›Paper›PMID 28783044›Full record

ArticleThe Journal of clinical investigation2017

Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia.

James S Ware, Louise V Wain, Sarath K Channavajjhala, Victoria E Jackson, Elizabeth Edwards, Run Lu, Keith Siew, Wenjing Jia, Nick Shrine, Sue Kinnear and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Guideline
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Hyponatraemia in ageing.Nature reviews. Endocrinology · 2025
    Review
  7. Article
  8. Article
  9. The biology of water homeostasis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

James S WareNIHR Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield, NHS Foundation Trust and Imperial College London, London, United Kingdom.
Louise V WainGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Sarath K ChannavajjhalaDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Victoria E JacksonGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Elizabeth EdwardsNIHR Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield, NHS Foundation Trust and Imperial College London, London, United Kingdom.
Run LuAlbert Einstein College of Medicine, Yeshiva University, New York, New York, USA.
Keith SiewClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom.
Wenjing JiaDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Nick ShrineGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Sue KinnearDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Mahli JallandDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Amanda P HenryDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Jenny ClaytonDepartment of Diabetes and Endocrinology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Kevin M O'ShaughnessyClinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom.
Martin D TobinGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Victor L SchusterAlbert Einstein College of Medicine, Yeshiva University, New York, New York, USA.
Stuart CookNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Ian P HallDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
Mark GloverDivision of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
University of Nottingham · GBUniversity of Leicester · GBAlbert Einstein College of Medicine · USRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity of Cambridge · GBNational University of Singapore · SGNottingham University Hospitals NHS Trust · GB

Funding

Medical Research Council G0902313Medical Research Council G1000861Medical Research Council MC_U120085815Medical Research Council MC_UP_1102/20Medical Research Council MR/L006162/1
6 · The paper itself

Abstract

Thiazide diuretics are among the most widely used treatments for hypertension, but thiazide-induced hyponatremia (TIH), a clinically significant adverse effect, is poorly understood. Here, we have studied the phenotypic and genetic characteristics of patients hospitalized with TIH. In a cohort of 109 TIH patients, those with severe TIH displayed an extended phenotype of intravascular volume expansion, increased free water reabsorption, urinary prostaglandin E2 excretion, and reduced excretion of serum chloride, magnesium, zinc, and antidiuretic hormone. GWAS in a separate cohort of 48 TIH patients and 2,922 controls from the 1958 British birth cohort identified an additional 14 regions associated with TIH. We identified a suggestive association with a variant in SLCO2A1, which encodes a prostaglandin transporter in the distal nephron. Resequencing of SLCO2A1 revealed a nonsynonymous variant, rs34550074 (p.A396T), and association with this SNP was replicated in a second cohort of TIH cases. TIH patients with the p.A396T variant demonstrated increased urinary excretion of prostaglandin E2 and metabolites. Moreover, the SLCO2A1 phospho-mimic p.A396E showed loss of transporter function in vitro. These findings indicate that the phenotype of TIH involves a more extensive metabolic derangement than previously recognized. We propose one mechanism underlying TIH development in a subgroup of patients in which SLCO2A1 regulation is altered.

Indexed as

AgedAged, 80 and overAquaporin 1Aquaporin 2Cohort StudiesDinoprostoneFemaleGenome-Wide Association StudyHumansHyponatremiaMaleMiddle AgedNephronsOrganic Anion TransportersPharmacogeneticsPhenotypeAQP1 protein, humanAQP2 protein, humanAquaporin 1Aquaporin 2DinoprostoneOrganic Anion TransportersProstaglandinsSLCO2A1 protein, humanSodium Chloride Symporter InhibitorsThiazidesWater

Identifiers

PMID28783044
PMCPMC5669583
OpenAlexW2744140635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.